0001596783-23-000062.txt : 20230803 0001596783-23-000062.hdr.sgml : 20230803 20230803164717 ACCESSION NUMBER: 0001596783-23-000062 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230801 FILED AS OF DATE: 20230803 DATE AS OF CHANGE: 20230803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hopson Ricky CENTRAL INDEX KEY: 0001862832 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36587 FILM NUMBER: 231140883 MAIL ADDRESS: STREET 1: CATALENT, INC. STREET 2: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Catalent, Inc. CENTRAL INDEX KEY: 0001596783 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208737688 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: (732) 537-6200 MAIL ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: PTS Holdings Corp. DATE OF NAME CHANGE: 20140113 4 1 wf-form4_169109561564021.xml FORM 4 X0508 4 2023-08-01 0 0001596783 Catalent, Inc. CTLT 0001862832 Hopson Ricky C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 0 1 0 0 Pres. Clinical Dev Supply Div 0 Common Stock 2023-08-01 4 S 0 195 47.86 D 16257 D Common Stock 2023-08-01 4 A 0 4790 0 A 21047 D Options to purchase Common Stock 46.51 2023-08-01 4 A 0 10669 0 A 2033-08-01 Common Stock 10669.0 10669 D Shares sold by the reporting person through an automatic "sell-to-cover" transaction to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $47.72 to $48.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes restricted stock units. Restricted stock units received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur in three equal annual installments beginning on August 1, 2024. Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. The options vest and become exercisable in four equal annual installments beginning on August 1, 2024. /s/ Amy Fallone, attorney-in-fact 2023-08-03